ABCA1通过调节Cav1/eNOS/NO信号通路调控眼压
本研究探讨ATP结合盒转运体A1(ABCA1)在调控眼压和房水流出中的作用及病理生理机制。发现POAG患者小梁网组织中ABCA1表达显著升高;在猪房角水丛细胞中,ABCA1上调通过caveolin-1/eNOS/NO通路降低跨内皮电阻并增加NO浓度,而ABCA1激动剂GW3965可降低眼压并增加传统流出易度。ABCA1是治疗青光眼和高眼压的新颖治疗候选靶点。
要点
- POAG患者小梁网组织中ABCA1表达显著高于对照。
- ABCA1上调通过caveolin-1/eNOS/NO通路降低跨内皮电阻并增加NO。
- GW3965降低眼压并显著增加传统流出易度。
核心结论
- ABCA1通过caveolin-1/内皮型一氧化氮合酶/NO通路调节房水流出,这是区别于其胆固醇外排传统功能的新功能。
- ABCA1是治疗青光眼和高眼压的有力新颖治疗候选靶点。
研究设计与样本
- 研究测量了POAG患者和人类供体眼小梁网样本中ABCA1的表达。
- 对猪房角水丛细胞(相当于人Schlemm管内皮细胞)给予ABCA1激动剂GW3965或转导表达ABCA1-shRNA的慢病毒。
- 测量跨内皮电阻、蛋白表达和NO浓度,并通过前房内注射给予GW3965后测量眼压和房水流出易度。
主要发现
- POAG患者小梁网组织中ABCA1表达显著高于对照。
- 房角水丛细胞中ABCA1上调降低跨内皮电阻,caveolin-1表达降低0.56倍,内皮型一氧化氮合酶表达和NO浓度分别增加2.85倍和1.17倍(n=3,P<0.05)。
- ABCA1下调增加跨内皮电阻和caveolin-1表达,降低内皮型一氧化氮合酶表达和NO生成(n=3,P<0.05)。
- GW3965降低眼压并显著增加传统流出易度(P<0.05)。
临床怎么用
- ABCA1及其下游caveolin-1/eNOS/NO通路可作为青光眼和高眼压的潜在治疗靶点。
- ABCA1激动剂GW3965在实验模型中降低眼压并改善传统流出易度,支持其作为候选药物的进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to investigate the role and pathophysiological mechanism of ATP binding cassette transporter A1 (ABCA1) in regulating the IOP and aqueous humor outflow. METHODS: ABCA1 expression was measured in trabecular meshwork samples obtained from patients with POAG and human donor eyes by Western blot. To further evaluate the functional significance of ABCA1, porcine angular aqueous plexus (AAP) cells, which are equivalent to human Schlemm's canal endothelial cells, were either treated with ABCA1 agonist GW3965 or transduced with lentivirus expressing ABCA1-shRNA. Transendothelial electrical resistance, protein expression, and nitric oxide (NO) concentration were measured. GW3965 was administered by intracameral injection. IOP and aqueous humor outflow facility were also measured. RESULTS: ABCA1 expression was significantly higher in the trabecular meshwork tissue of patients with POAG compared with controls. ABCA1 upregulation in angular aqueous plexus cells decreased the transendothelial electrical resistance in the angular aqueous plexus monolayers accompanied by a 0.56-fold decrease in caveolin-1 expression and a 2.85-fold and 1.17-fold increase in endothelial NO synthase expression and NO concentration, respectively (n = 3, P < 0.05). Conversely, ABCA1 downregulation increased transendothelial electrical resistance and caveolin-1 expression and decreased endothelial NO synthase expression and NO production (n = 3, P < 0.05). GW3965 decreased IOP and significantly increased conventional outflow facility (P < 0.05). CONCLUSIONS: Regulation of aqueous humor outflow via the caveolin-1/endothelial NO synthase/NO pathway is a newly defined function of ABCA1 that is different from its traditional role in mediating cholesterol efflux. ABCA1 is a compelling, novel therapeutic candidate for the treatment of glaucoma and ocular hypertension.
引用
- Hu C, Niu L, Li L, et al. ABCA1 Regulates IOP by Modulating Cav1/eNOS/NO Signaling Pathway. Invest Ophthalmol Vis Sci. 2020. PMID: 32428234. doi:10.1167/iovs.61.5.33
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。